BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $41,000 | +241.7% | 31,415 | +175.2% | 0.01% | +150.0% |
Q3 2019 | $12,000 | -36.8% | 11,415 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $19,000 | -50.0% | 11,415 | 0.0% | 0.00% | -60.0% |
Q1 2019 | $38,000 | -74.7% | 11,415 | -77.8% | 0.01% | -79.2% |
Q4 2018 | $150,000 | -51.5% | 51,415 | +2.6% | 0.02% | -42.9% |
Q3 2018 | $309,000 | -17.2% | 50,115 | -0.9% | 0.04% | -22.2% |
Q2 2018 | $373,000 | +14.4% | 50,545 | +1.7% | 0.05% | +10.2% |
Q1 2018 | $326,000 | -19.7% | 49,685 | +2.9% | 0.05% | -19.7% |
Q4 2017 | $406,000 | +185.9% | 48,285 | +293.0% | 0.06% | +165.2% |
Q3 2017 | $142,000 | -55.1% | 12,285 | -52.0% | 0.02% | -58.9% |
Q1 2017 | $316,000 | – | 25,585 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |